Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Buffers and Standards
  4. Chromatography Standards
  5. Drug Standards
  6. 111013026

Irbesartan Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™

Catalog No. 111013026 Shop All MilliporeSigma Supelco Products
Click to view available options
Quantity:
1 g

Description

Irbesartan is a potent, long-acting 'sartan' class, nonpeptide, angiotensin II receptor antagonist utilized for the management of hypertension as well as heart failure in clinical patients. It shows high selectivity for the AT1 subtype (angiotensin I), and effectively reduces the probabilities of cardiac failure, myocardial infarction, sudden death, etc.Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. Featured Industries: Pharmaceutical (small molecule)
TRUSTED_SUSTAINABILITY

Specifications

CAS 138402-11-6
Purity Grade Notes These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
Linear Formula C25H28N6 O
MDL Number MFCD00864464
Synonym 2-Butyl-3-[[2′-(2 H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1,3-diazaspiro[4.4 ]non-1-en-4-one
Type Certified Reference Material
Quantity 1 g
Formula Weight 428.53
Grade Certified Reference Material
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.